In spite of numerous recent articles on the application of new diagnostic methods in Duchenne muscular dystrophy, there appears to be no recent review of the natural dynamics of this disease or of the numerical consequences of artificial selection.
Since reproduction of affected subjects is extremely rare and heterozygotes are only rarely seriously weakened, the disease can be treated as an X linked lethal. This greatly simplifies the analysis. In general I will follow the terminology of Haldane1 2 and disclaim any originality.
First it is necessary to define both the terms and the symbols used. The Greek symbols of Haldane have been widely miscopied and occasionally inverted. Theta and psi, the recombination fraction and its complement, the non-recombination or cosegregation fraction, can also be romanised with advantage. The following will be used: We assume a steady state population, with equal numbers of boys and girls at birth, in which a proportion of boys q are, or will be, affected and a proportion h of girls, and later mothers, are heterozygotes or carriers. At.conception a proportion u of ova have a new mutation on their X chromosome, as do a proportion v of X bearing sperm. Haldane referred to these proportions, which are mutation rates, as mu and nu ([t, v) , the Greek m and n. It is convenient to write u and v which look similar and are also alphabetical neighbours. Later we will use w, the proportion of zygotes with a mutation acquired shortly after fertilisation. In addition to these new mutations, as half the ova of carriers convey the defect, and a proportion h of women are carriers, h/2 ova will be affected from a mutation in a previous generation.
We clearly have the following equalities. Boys (1) q = h/2 + u Girls
(2) h = h/2 + u + v (3) From (2) h = 2u + 2v (4) From (1,2) q = 2u + v and since either u or v could be zero the incidence of carriers in girls must be at least equal to the incidence of the disease in boys, but not more than twice this incidence. If, as seems consistent with most data, these mutation rates are similar, then, if they are assumed equal:
(5) The prospect of making any substantial reduction in the numbers born is distressingly low. Cases due to deficiencies,6 which might be the majority if a battery of probes within the critical segment were available, or if pulsed field electrophoresis were feasible for routine use, might allow DNA from male fetuses available from other routine procedures to be screened. As it is clear that the lesion is not consistent, and that most first cases in a family will differ from most other cases in the same population, any lesion except a deficiency may be resistant to any screening technique possible at present. However, a slight reduction in a common disease confers as much benefit as a major reduction in a rare disease, and screening male fetuses when amniocentesis or chorion biopsy is indicated for other purposes would be advantageous if reliable.
The question "what proportion of cases in a community has a common origin?" is frequently posed. A formal answer requires a knowledge of population structure, but approximations based on the mathematically simple population, in which Fetal sexing every woman has two children with an equal expectation of boys and girls, may give results close to a more realistic model, or may, after elaborate algebra involving multiple integrals, lead to very similar predictions due to parameters which are not obviously irrelevant largely cancelling out.7
The half life of the mutant is one generation, since only half the daughters will inherit it and none of the sons will transmit it. Similarly, only half the mothers of carriers will be carriers. The chance in an all-female pedigree of any woman being a carrier can be defined if the connection between any two women is described by writing M for mother and D for daughter. A sister is then MD, a first cousin MMDD, and so on. The chance of a mother of a carrier being a carrier is 1/2. The chance of a child being both a daughter and a carrier is 1/4, so that the risk is In practice the minimal error rate is usually between m/3z and m/Sz where m is the number of meioses connecting the known with the unknown phenotype. Table 3 shows the 'predictive' value for various values of the recombination fraction (t) and the maximum lod at which it occurs, using the approximation of Laplace,8 which is exact for an a priori rectangular distribution of possible values of theta from 0 to 1-0. The fact that this distribution is limited to 0 to 0*5 makes little difference if the linkage is tight.
Fortunately these limitations are rapidly ceasing to be realistic problems now that there are bracketing variants in Duchenne. Provided that there are no crossovers between these, and they are fairly close, the chance of error due to a double recombination cannot be more than (t/2)2 where t is the predictive recombination fraction between the bracketing loci. Although not obvious, the worst case is that in which the disease locus is exactly midway between the bracketing loci. The possibility of one crossover between bracketing loci, leading to a 'grey area' of uncertainty, has to be considered in any assessment of risk of a procedure. Where this is ignored, very high precision has been claimed. The chance of a crossover leading, in practice, to termination is as discussed above; the chance of the fetus being affected is dependent on the position of the disease locus. In practice the act of recombination usually inhibits nearby recombination, and even more reliable predictions may be expected.
If The serious problem, which is not resolved by any number of probes, however close, is the inability to define whether the Duchenne locus is normal or mutant unless the potential carrier's mother is known to be a carrier. This is a most serious limitation, since this limits control with low casualty rates to a proportion of potential carriers in that minority of families with more than one affected member. The casualty rate of normal fetuses must increase rapidly as the circle of anxiety, or of intervention, extends from the mother of the known case to other female relatives.
If we consider the sporadic case without further evidence (fig 3) , then terminating sons with the The proportions of the four possible outcomes, true positive, false positive, false negative, and true negative (fig 7) , are easily computed. In practice these two types of error have very different implications.
The error, failure, and casualty rates are given in table 4. In words, the failure rate is the proportion of those tested who are affected, but were thought not to be, and the casualty rate is the proportion of those who were not affected, but thought to be. The sum of these gives the total error rate. The acceptability of any procedure based on termination must depend on the size of these two errors and the severity of the condition, and will differ from condition to condition, and from person to person. Fig 5 and table 4 show the failure and casualty rates for various relatives ignoring the substantial information available from creatine kinase. It is clear that the casualty rate rapidly becomes excessive, and this is mainly due to mutation rather than recombination, even with loosely linked probes.
The estimation of carrier status using information from normal males The risk of a woman being a carrier, connected in any pedigree to the closest known carrier through female relatives, is easily calculated if the mitigating effects of the normal male are ignored. This risk fades into insignificance, in practical terms, by the third counsinship.
Where allowance is to be made for normal males, or for likelihood ratios based on creatine kinase or related tests, the probability is most easily computed by working in odds ratios. These are directly related to probabilities, but lead to simpler arithmetic: they are also more easily comprehended by most relatives of patients, since the language of betting is more widely understood than that of probabilities. If the odds ratio is expressed as a:b the probability is a/(a+b).
The mother whose only son is affected, and who knows nothing of her family history, has, assuming equal mutation rates from male and female, a probability of 2/3 of being a carrier and 1/3 of not being a carrier.
Her odds ratio for being a carrier is: 2/3 : 1/3 or 2:1. As half the carriers have a carrier mother, the three categories of (1) grandmother and mother carriers, (2) mother only a carrier, and (3) neither a carrier are necessarily equal, with an odds ratio of 2:1 1:1:1 (fig 3) . possibilities (fig 3) . In the first, the mutation is found in the affected boy, but not in his mother. In the second, it is conveyed through his mother, but not derived from her mother. In the third, it is conveyed through both his mother and her mother. These can be displayed in the form of a simple spread-sheet, and this is shown in tables 5 and 6, and with a worked example (table 7) .
Information from probes is easily accommodated, although the circumstances are so variable that it is difficult to advance a generalised approach. The estimated recombination fraction must be modified to the predictive form, as discussed above. In practice, probe data are easy to interpret from annotated pedigrees when there has been no crossover: when a crossover has occurred even approximate predictions may be difficult (exact ones are impossible). In programmes has yet been made on simulated data. In practise, this is a field in which molecular biology is advancing faster than methods of statistical analysis, which will become irrelevant as soon as TABLE 10 Computation oflikelihoods for similar case involving bracketing loci C and E and the Duchenne locus D. Recombination between CD and DE assumed to be 0 1. The factor 114 for each son omitted (these cancel out). On these data the probability ofthe mother being a carrier is about 15%. For clarity, such terms as p,t2 are written pt, the order defining the subscript. 
